Clinical Pipeline Hub
Hub-and-Spoke View of Regenverse Clinical Programs
Track our pluripotent stem cell-derived therapeutics as they advance through discovery, CMC scale-up, pre-clinical validation, and early clinical readiness. Click any program row to deep-dive into indication-specific strategy, mechanism, and evidence.
Neurology
iPSC-derived neurons engineered for precise circuit reconstruction in Parkinson's and Huntington's disease.
Oncology
Next-generation immune effector cells tuned for solid tumor microenvironments and scalable allogeneic dosing.
Interactive Development Roadmap
Hover for annotations and click a row for detailed scientific narratives.
Regulatory Pathing
CMC packages and comparability strategies are harmonized across programs to accelerate IND-enabling studies and multi-jurisdiction filings.
Manufacturing Backbone
A single GMP iPSC master cell bank supports neuron and NK cell differentiation, enabling spoke-specific customizations without resetting process validation.
Biomarker Intelligence
Multi-omics dashboards monitor potency, synaptic connectivity, and cytotoxic signatures, ensuring quality thresholds stay above clinical release criteria.